By combining affinity proteomics and gene expression analysis, a small molecule, referred to as lung cancer screen 1 (LCS-1) is identified as SOD1 inhibitor and reduces the growth of lung adenocarcinoma cell lines (14). Here, SOD1 is linked to lung carcinoma.